disulfiram has been researched along with 7-hydroxycoumarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; Ge, G; Lin, GQ; Tian, P; Wang, F; Xiong, Y; Yang, X; Zhang, FM; Zhang, JW | 1 |
| Baxter, PJ; Hankins, DC; Kharasch, ED; Thummel, KE | 1 |
1 trial(s) available for disulfiram and 7-hydroxycoumarin
| Article | Year |
|---|---|
Single-dose disulfiram does not inhibit CYP2A6 activity.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disulfiram; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Mixed Function Oxygenases; Umbelliferones | 1998 |
1 other study(ies) available for disulfiram and 7-hydroxycoumarin
| Article | Year |
|---|---|
Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CL
Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Gastrointestinal Tract; Humans; Kinetics; Microsomes, Liver; Molecular Docking Simulation; Protein Binding; Structure-Activity Relationship; Viral Nonstructural Proteins | 2022 |